Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.

Fowler AM, Chan SR, Sharp TL, Fettig NM, Zhou D, Dence CS, Carlson KE, Jeyakumar M, Katzenellenbogen JA, Schreiber RD, Welch MJ.

J Nucl Med. 2012 Jul;53(7):1119-26. doi: 10.2967/jnumed.112.103465. Epub 2012 Jun 5.

2.

Longitudinal noninvasive imaging of progesterone receptor as a predictive biomarker of tumor responsiveness to estrogen deprivation therapy.

Chan SR, Fowler AM, Allen JA, Zhou D, Dence CS, Sharp TL, Fettig NM, Dehdashti F, Katzenellenbogen JA.

Clin Cancer Res. 2015 Mar 1;21(5):1063-70. doi: 10.1158/1078-0432.CCR-14-1715. Epub 2014 Dec 17.

3.

[18F]-fluoroestradiol quantitative PET imaging to differentiate ER+ and ERα-knockdown breast tumors in mice.

Paquette M, Ouellet R, Archambault M, Croteau É, Lecomte R, Bénard F.

Nucl Med Biol. 2012 Jan;39(1):57-64. doi: 10.1016/j.nucmedbio.2011.06.004. Epub 2011 Nov 12.

PMID:
22079037
4.

Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader.

Heidari P, Deng F, Esfahani SA, Leece AK, Shoup TM, Vasdev N, Mahmood U.

Clin Cancer Res. 2015 Mar 15;21(6):1340-7. doi: 10.1158/1078-0432.CCR-14-1178. Epub 2015 Jan 21.

5.

Assessment of the novel estrogen receptor PET tracer 4-fluoro-11β-methoxy-16α-[(18)F]fluoroestradiol (4FMFES) by PET imaging in a breast cancer murine model.

Paquette M, Phoenix S, Ouellet R, Langlois R, van Lier JE, Turcotte EE, Bénard F, Lecomte R.

Mol Imaging Biol. 2013 Oct;15(5):625-32. doi: 10.1007/s11307-013-0638-7.

PMID:
23619898
6.

PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer.

Dehdashti F, Mortimer JE, Trinkaus K, Naughton MJ, Ellis M, Katzenellenbogen JA, Welch MJ, Siegel BA.

Breast Cancer Res Treat. 2009 Feb;113(3):509-17. doi: 10.1007/s10549-008-9953-0. Epub 2008 Mar 9.

7.

STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.

Chan SR, Vermi W, Luo J, Lucini L, Rickert C, Fowler AM, Lonardi S, Arthur C, Young LJ, Levy DE, Welch MJ, Cardiff RD, Schreiber RD.

Breast Cancer Res. 2012 Jan 20;14(1):R16.

8.

18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis.

Zhao Z, Yoshida Y, Kurokawa T, Kiyono Y, Mori T, Okazawa H.

J Nucl Med. 2013 Apr;54(4):499-506. doi: 10.2967/jnumed.112.113472. Epub 2013 Mar 7.

9.

Assessment of estrogen receptor expression in epithelial ovarian cancer patients using 16α-18F-fluoro-17β-estradiol PET/CT.

van Kruchten M, de Vries EF, Arts HJ, Jager NM, Bongaerts AH, Glaudemans AW, Hollema H, de Vries EG, Hospers GA, Reyners AK.

J Nucl Med. 2015 Jan;56(1):50-5. doi: 10.2967/jnumed.114.147579. Epub 2014 Dec 4.

10.

Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione.

Dehdashti F, Laforest R, Gao F, Aft RL, Dence CS, Zhou D, Shoghi KI, Siegel BA, Katzenellenbogen JA, Welch MJ.

J Nucl Med. 2012 Mar;53(3):363-70. doi: 10.2967/jnumed.111.098319. Epub 2012 Feb 13.

11.

Functional oestrogen receptor α imaging in endometrial carcinoma using 16α-[¹⁸F]fluoro-17β-oestradiol PET.

Tsujikawa T, Yoshida Y, Kiyono Y, Kurokawa T, Kudo T, Fujibayashi Y, Kotsuji F, Okazawa H.

Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):37-45. doi: 10.1007/s00259-010-1589-8. Epub 2010 Aug 18.

PMID:
20717823
12.

Metabolic flare: indicator of hormone responsiveness in advanced breast cancer.

Mortimer JE, Dehdashti F, Siegel BA, Trinkaus K, Katzenellenbogen JA, Welch MJ.

J Clin Oncol. 2001 Jun 1;19(11):2797-803.

PMID:
11387350
13.

Breast cancer models to study the expression of estrogen receptors with small animal PET imaging.

Aliaga A, Rousseau JA, Ouellette R, Cadorette J, van Lier JE, Lecomte R, Bénard F.

Nucl Med Biol. 2004 Aug;31(6):761-70.

PMID:
15246367
14.
15.

18F-fluoromisonidazole PET/CT: a potential tool for predicting primary endocrine therapy resistance in breast cancer.

Cheng J, Lei L, Xu J, Sun Y, Zhang Y, Wang X, Pan L, Shao Z, Zhang Y, Liu G.

J Nucl Med. 2013 Mar;54(3):333-40. doi: 10.2967/jnumed.112.111963. Epub 2013 Feb 11.

16.

Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer.

Linden HM, Stekhova SA, Link JM, Gralow JR, Livingston RB, Ellis GK, Petra PH, Peterson LM, Schubert EK, Dunnwald LK, Krohn KA, Mankoff DA.

J Clin Oncol. 2006 Jun 20;24(18):2793-9. Epub 2006 May 8.

PMID:
16682724
17.

Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer.

Gemignani ML, Patil S, Seshan VE, Sampson M, Humm JL, Lewis JS, Brogi E, Larson SM, Morrow M, Pandit-Taskar N.

J Nucl Med. 2013 Oct;54(10):1697-702. doi: 10.2967/jnumed.112.113373. Epub 2013 Aug 22.

18.

A small animal positron emission tomography study of the effect of chemotherapy and hormonal therapy on the uptake of 2-deoxy-2-[F-18]fluoro-D-glucose in murine models of breast cancer.

Aliaga A, Rousseau JA, Cadorette J, Croteau E, van Lier JE, Lecomte R, Bénard F.

Mol Imaging Biol. 2007 May-Jun;9(3):144-50.

PMID:
17334852
19.

Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer.

Linden HM, Kurland BF, Peterson LM, Schubert EK, Gralow JR, Specht JM, Ellis GK, Lawton TJ, Livingston RB, Petra PH, Link JM, Krohn KA, Mankoff DA.

Clin Cancer Res. 2011 Jul 15;17(14):4799-805. doi: 10.1158/1078-0432.CCR-10-3321. Epub 2011 Jul 12.

20.

Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.

Talbot JN, Gligorov J, Nataf V, Montravers F, Huchet V, Michaud L, Ohnona J, Balogova S, Cussenot O, Daraï E, Lotz JP, Kerrou K.

Q J Nucl Med Mol Imaging. 2015 Mar;59(1):4-17. Epub 2015 Feb 19. Review.

Supplemental Content

Support Center